Verisante Technology (VRSEF) Stock Price, News & Analysis

Company Overview

Verisante Technology Inc. is a Canada-based medical device company focused on the development and commercialization of non-invasive cancer detection systems. The firm’s flagship offering, the Verisante Aurora, employs Raman spectroscopy and digital imaging to analyze tissue at the point of care, aiming to differentiate malignant lesions from benign skin abnormalities. By integrating optical spectroscopy with advanced data algorithms, Verisante seeks to provide clinicians with real-time diagnostic support for early-stage melanoma, basal cell carcinoma and squamous cell carcinoma.

In addition to its dermatology application, Verisante has extended its technology platform toward pulmonary oncology, exploring handheld spectroscopic devices to assist in the detection of early lung cancer during bronchoscopy procedures. The company’s research and development efforts have been supported through collaborations with academic institutions and clinical centers in North America and Europe, where Aurora prototypes have undergone pilot testing in hospital and outpatient settings.

Headquartered in Vancouver, British Columbia, Verisante maintains operations and regulatory support teams in Europe to address CE-mark requirements and engage local distributors. The company’s management team combines expertise in medical optics, regulatory affairs and commercialization strategy, positioning Verisante to address the global need for rapid, minimally invasive cancer screening tools.

Key Stats

• Today's Range: $0.01 to $0.01
• 50-Day Range: $0.0022 to $0.01
• 52-Week Range: $0.0021 to $0.01
• Volume: 542 shs
• Average Volume: 3,178 shs
• Market Capitalization: $439.38 thousand
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

VRSEF Stock Analysis - Frequently Asked Questions

How have VRSEF shares performed this year?

Verisante Technology's stock was trading at $0.0050 at the beginning of 2025. Since then, VRSEF stock has increased by 100.0% and is now trading at $0.01.

When did Verisante Technology's stock split?

Verisante Technology shares reverse split before market open on Thursday, June 23rd 2022.The 1-10 reverse split was announced on Thursday, June 23rd 2022. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, June 23rd 2022. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

How do I buy shares of Verisante Technology?

Shares of VRSEF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 10/16/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: MED INSTRUMENTS
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:VRSEF
• CIK: N/A
• Web: www.verisante.com
• Phone: (604) 716-5133
• Fax: 604-605-0508
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$80 thousand
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: -1,204.19%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.17
• Quick Ratio: 0.17

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 43,940,000
• Free Float: N/A
• Market Cap: $439.40 thousand
• Optionable: Not Optionable
• Beta: 18.93